According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points  PHC has ...